These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3072347)

  • 21. Renal hemodynamic effects of ketanserin therapy in essential hypertension.
    Ram CV; Gonzalez DG; Kaplan NM; Ralakis JM; Henderson JD; Lugo CE; Zachariah N
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S78-80. PubMed ID: 2446078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of ketanserin on blood pressure and biochemical parameters in treated patients with essential hypertension.
    Wing LM; Chalmers JP; West MJ; Bune AJ; Ayres B; Graham JR
    Clin Exp Hypertens A; 1984; 6(6):1107-17. PubMed ID: 6146414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of acute and chronic effects of ketanserin in the treatment of hypertension and hypothesis on a new mechanism of action].
    Sechi LA
    Ann Ital Med Int; 1990; 5(4 Pt 2):433-50. PubMed ID: 2102130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Double-blind comparison of ketanserin with placebo in patients with essential hypertension.
    Wellens D; Peeters G; Baeten B; Sieben G; Symoens J
    Angiology; 1986 Nov; 37(11):810-7. PubMed ID: 3538945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A double-blind comparative study of ketanserin with atenolol in essential hypertension.
    Antonicelli R; Andreoni A; Saccomanno G; Gambini C; Paciaroni E
    Drugs Exp Clin Res; 1989; 15(11-12):577-81. PubMed ID: 2700320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of the 5-hydroxytryptamine type 2 receptor antagonist, ketanserin, on blood pressure, the renin-angiotensin system and sympatho-adrenal function in patients with essential hypertension.
    Zabludowski JR; Zoccali C; Isles CG; Murray GD; Robertson JI; Inglis GC; Fraser R; Ball SG
    Br J Clin Pharmacol; 1984 Mar; 17(3):309-16. PubMed ID: 6712863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ketanserin in mild to moderate hypertension in the elderly: a double-blind study versus methyldopa.
    Cattin L; Da Col PG
    Clin Ther; 1989; 11(3):363-72. PubMed ID: 2663164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ketanserin in the acute management of severe hypertension.
    Murphy BF; Whitworth JA; Kincaid-Smith P
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S168-71. PubMed ID: 2412044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 5-HT, alpha-adrenoceptors, and blood pressure. Effects of ketanserin in essential hypertension and autonomic insufficiency.
    Wenting GJ; Woittiez AJ; Man in't Veld AJ; Schalekamp MA
    Hypertension; 1984; 6(1):100-9. PubMed ID: 6319278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experience with ketanserin and ritanserin in hypertensive patients.
    Hedner T; Persson B
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S44-8. PubMed ID: 2459514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antihypertensive efficacy of ketanserin alone or in combination with a beta-blocker or a diuretic: the Swiss Ketanserin Study.
    Beretta-Piccoli C; Amstein R; Bertel O; Brunner HR; Bühler FR; Follath F; Solèr M; Vallotton M
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S119-23. PubMed ID: 2446058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of a new antihypertensive agent ketanserin versus methyldopa in the treatment of essential hypertension in older patients: an international multicenter trial.
    Zin C; Copertari P; Landi E; San Martin C; Lopes M; Feruglio F; Alcocer L
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S113-8. PubMed ID: 2446057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ketanserin in the treatment of essential hypertension. A double-blind study against metoprolol and a further long-term open treatment.
    Milei J; Lemus J; Bernardiner E
    Acta Cardiol; 1986; 41(6):427-41. PubMed ID: 3544622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of ketanserin on blood pressure and platelet aggregation in elderly men with mild hypertension.
    Egan B; Conlon ME; Campbell R; Schork N; Zwiefler A; Julius S
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):324S-330S. PubMed ID: 3415805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative antihypertensive effects of ketanserin and a ketanserin-hydrochlorothiazide combination administered once daily.
    Leary WP; Reyes AJ; van der Byl K; Maharaj B
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S127-34. PubMed ID: 2446061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hemodynamic and humoral effects of 2 different doses of ketanserin in aged patients with hypertension].
    Rizzoni D; Castellano M; Beschi M; Agabiti-Rosei E
    Ann Ital Med Int; 1990; 5(4 Pt 2):489-96. PubMed ID: 2102136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Main results of the ouabain and adducin for Specific Intervention on Sodium in Hypertension Trial (OASIS-HT): a randomized placebo-controlled phase-2 dose-finding study of rostafuroxin.
    Staessen JA; Thijs L; Stolarz-Skrzypek K; Bacchieri A; Barton J; Espositi ED; de Leeuw PW; Dłużniewski M; Glorioso N; Januszewicz A; Manunta P; Milyagin V; Nikitin Y; Souček M; Lanzani C; Citterio L; Timio M; Tykarski A; Ferrari P; Valentini G; Kawecka-Jaszcz K; Bianchi G
    Trials; 2011 Jan; 12():13. PubMed ID: 21235787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ketanserin, hypertension, and chronic alcoholism: double-blind study in forty patients.
    de Lorenzo A; Ceccanti M; Assogna G; Romeo M; Cavaleri G; Attilia ML
    Int J Clin Pharmacol Res; 1988; 8(5):321-5. PubMed ID: 3068159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effects of chronic antihypertensive treatment with ketanserin versus metoprolol on blood pressure and compliance of great arteries in man: a double-blind crossover study].
    Crispino M
    Ann Ital Med Int; 1990; 5(4 Pt 2):469-76. PubMed ID: 2102134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does acute serotonergic type-2 antagonism reduce blood pressure? Comparative effects of single doses of ritanserin and ketanserin in essential hypertension.
    Hosie J; Stott DJ; Robertson JI; Ball SG
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S86-8. PubMed ID: 2446081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.